Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
•
Primary Care
Is there any role in continuing apixaban in a patient with occlusion of the right internal jugular vein with chronic postthrombotic change to prevent a recurrent DVT?
Previous provoking factors resolved (CVC, malignancy, etc)
Answer from: at Academic Institution
Yes
Sign In
or
Register
to read more
15620
Related Questions
How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE (hereditary thrombophilia without personal thrombosis, family history of thrombophilia or thrombosis, etc.)?
For patients with a history of pregnancy loss, do you evaluate for PAI-1 polymorphisms as part of a thrombophilia workup?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
How often do you check weight and adjust anticoagulation dosing in pregnancy?
How long would you anticoagulate a patient with recurrent VTE who has ongoing risk factors for intracranial bleeding?
Would you recommend anticoagulation in subsequent pregnancies after symptomatic postpartum R ovarian vein thrombosis?
What is your preferred management for renal artery thrombosis causing renal infarct of unclear etiology?
What is your approach to the management of unprovoked distal DVTs?
How would you manage symptomatic superficial vein thrombosis during pregnancy?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?